Company intelligence / Profile preview

Biotech Développement Conseils

Ownership: Public · BDC
Development stage: Other

Overview

Biotech Développement Conseils (BDC) specializes in corporate strategy and business development for life sciences companies. Founded in 2002 by former healthcare industry executives, BDC supports start-ups to large pharma with strategic advice on asset valuation, market assessment, due diligence, partner identification and deal negotiation. The company leverages deep scientific expertise and an extensive international network to help clients maximize the value of their innovations before they reach the market. BDC has advised over 200 companies globally across biotechnology, pharmaceuticals, diagnostics/platforms/instrumentation/e-health sectors.

Industry: Consulting

Financials

Market cap: $4.6B
Total revenue: $750.2M
Enterprise value: $5.6B

Beyond the preview

Go deeper on Biotech Développement Conseils.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biotech Développement Conseils.

Explore the full profile